Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2000
03/22/2000EP0986402A2 Reversible geling co-polymer and method of making
03/22/2000EP0986392A1 Method of treating chronic progressive vascular scarring diseases
03/22/2000EP0986374A2 Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin
03/22/2000EP0986373A1 Drug targeting system, method of its preparation and its use
03/22/2000EP0986372A1 Vesicular complexes and methods of making and using the same
03/22/2000EP0986367A1 Spray compositions
03/22/2000EP0986309A1 Uses of oil bodies
03/22/2000EP0866814B1 Copolymers of olefinically unsaturated monocarboxylic acids, olefinically unsaturated dicarboxylic acids or their anhydrides or mixtures of such carboxylic acids or anhydrides and their use as thickeners and dispersants
03/22/2000EP0860170B1 Tablets based on isotope-labeled urea
03/22/2000EP0804203B1 Rectal flunisolide compositions for treating inflammatory intestinal disorders
03/22/2000EP0782442A4 A delivery system for antimethanogenic agents
03/22/2000EP0772776B1 Superparamagnetic particles, process for their production and their use
03/22/2000EP0725625B1 Gelatin capsule fill able to foam
03/22/2000EP0705085B1 Molecular transdermal transport system
03/22/2000EP0671912B1 Injectable taxane derivative based compositions
03/22/2000EP0506774B2 Smoking substitute
03/22/2000CN1248177A Coated particles, method of making and using
03/22/2000CN1248167A Administration of injectable antibiotic in ear of animal
03/22/2000CN1248165A Nimesulide gel system for topical use
03/22/2000CN1248163A Pharmaceutical preparation comprising lyophilized lipsomes encapsulating active principle which is highly insoluble in water, and the process for preparing the said preparation
03/22/2000CN1248162A Topical pharmaceutical composition comprising cholinergic agent or calcium channel blocker
03/22/2000CN1248155A Compositions to control oral microbial oxidation-reduction (Eh) levels
03/22/2000CN1247757A Cancer treating medicine capsule
03/22/2000CN1247754A Medicine ointment for skin allergy caused by violet ray and cosmetics, dermatitis and other skin diseases
03/22/2000CN1247753A Toothache pill (powder)
03/22/2000CN1247749A Medicine liquid capable of activating blood circulation to dissipate blood stasis, nourishing Yin, protecting Yang and treating soft tissue injury
03/22/2000CN1247741A Emulsified inhalational anaesthetic for intravenous injection and its preparation
03/22/2000CN1050534C Process for preparation of dry processed particles
03/22/2000CN1050519C Chinese medicine granule for treatment of acne
03/22/2000CN1050514C Antiallergic composition for ophthalmic or nasal use
03/22/2000CN1050513C Catalyst for pipe type deodorizer and its coating technology
03/21/2000US6041253 Electroporation, vacuum or mechanical pressure.
03/21/2000US6040434 Screening for compound which reduces or prevents formation of 3'-amino-3'-deoxythymidine from 3'-azido-3'-deoxythymidine (azt); side effect reduction in mammals receiving viricidal therapy
03/21/2000US6040344 Crystalline r,r-formoterol l-(+)-tartrate.
03/21/2000US6040343 Remedy for keratoconjunctival diseases
03/21/2000US6040301 Oral liquid antidepressant solution
03/21/2000US6040300 Administering an anticarcinogenic agents
03/21/2000US6040297 A therapeutic agents treating tumors and retroviral infections including hiv infections
03/21/2000US6040295 Prolong the bioavailability of a nucleic acid molecule by injecting a solutions comprising a nucleic acid molecule and an amphiphilic compound select from polyvinyl pyrrolidone, polyvinyl alcohol, polyethylene glycol or propylene glycol
03/21/2000US6040167 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
03/21/2000US6039981 Itraconazole, phosphoric acid with carriers as fungicides
03/21/2000US6039980 Drug with sustained release excipient
03/21/2000US6039979 Time release of drugs for sustained periods using polymer that is hydrosoluble with coatings for gastric and intestines
03/21/2000US6039977 Water and polyvinyl alcohol with drug to form hydrogel for drug delivery
03/21/2000US6039976 Enteric film coating compositions, method of coating therewith, and coated forms
03/21/2000US6039975 Colon targeted delivery system
03/21/2000US6039974 Drugs of multilayer tablets
03/21/2000US6039971 Composition for skin patch preparation and process for preparing the same
03/21/2000US6039970 Nasal administering bioactive drugs with hyaluronic acid derivatives, dissolving in dimethyl sulfoxide, adding to mineral oil, ethyl acetate, filtration
03/21/2000US6039968 Active materials and polymer matrices
03/21/2000US6039967 Intravesical drug delivery system
03/21/2000US6039963 Ceramide compounds, process for their preparation and use
03/21/2000US6039943 Removal of blood from vitreous humor of blood
03/21/2000US6039940 Inherently antimicrobial quaternary amine hydrogel wound dressings
03/21/2000US6039936 Nanoemulsion based on non-ionic and cationic amphiphilic lipids and uses thereof
03/21/2000US6039932 Administering by mouth or nose
03/21/2000US6039900 Particulate polymeric materials and their production
03/21/2000US6039813 Fructose-based granulated product and a process for the production thereof
03/21/2000US6039557 Apparatus for making gas-filled vesicles of optimal size
03/16/2000WO2000014155A1 Erodible solid hydrogels for delivery of biologically active materials
03/16/2000WO2000014019A1 A medical active water, manufacture and use thereof
03/16/2000WO2000013711A1 Pharmaceutical composition containing calcium valproate with delayed active substance release and method for the production of said composition
03/16/2000WO2000013710A2 Hydrogel compositions for the controlled release administration of growth factors
03/16/2000WO2000013696A1 Composition for improving mental capabilities in mammals
03/16/2000WO2000013692A1 Ophthalmic compositions and process of using
03/16/2000WO2000013687A2 Sustained release ranolazine formulations
03/16/2000WO2000013686A2 Sustained release ranolazine formulations
03/16/2000WO2000013680A2 Filamentous amorphous carbohydrate compositions and therapeutic delivery vehicles comprising them
03/16/2000WO2000013679A1 Plaster containing a medicament, with three functional layers
03/16/2000WO2000013678A1 Extended release acetaminophen
03/16/2000WO2000013677A1 Nanogel networks and biological agent composition thereof
03/16/2000WO2000013676A1 A ph-dependent drug release composition
03/16/2000WO2000013675A1 Methazolamide compositions and method of use
03/16/2000WO2000013674A1 Dosage form comprising therapeutic formulation
03/16/2000WO2000013673A1 Extended release acetaminophen
03/16/2000WO2000013672A1 New solid dose form of nanoparticulate naproxen
03/16/2000WO2000013671A1 Immediate release tablet
03/16/2000WO2000013670A1 Extended release acetaminophen
03/16/2000WO2000013669A1 Extended release acetaminophen
03/16/2000WO2000013668A1 Microparticles
03/16/2000WO2000013667A1 Lipstatin derivative-soluble fiber tablets
03/16/2000WO2000013666A1 Biodegradable particulate polymeric preparation and process for producing thereof
03/16/2000WO2000013665A1 Controlled release drug delivery
03/16/2000WO2000013664A1 Drug preparations for treating sexual dysfunction
03/16/2000WO2000013663A1 Dosage form comprising liquid formulation
03/16/2000WO2000013662A2 Medicated chewing gum delivery system for nicotine
03/16/2000WO2000013653A1 Organosilicone compositions for personal care
03/16/2000WO2000013647A1 Method and device for producing tablets
03/16/2000WO2000013476A2 A bubble drop and method of making same
03/16/2000WO2000000209A3 Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions
03/16/2000WO1999064598A3 Novel insulin analogs with enhanced zinc binding
03/16/2000WO1999059643A3 Liposomal delivery complex
03/16/2000DE19849017C1 Dressing for promoting wound healing contains a viscous oily extract of cinnamon leaves
03/16/2000DE19841798A1 Nonionic and/or amphoteric surfactant-containing water-in-oil emulsions containing surfactive additive such as PEG-30 dipolyhydroxystearate to allow incorporation of UV filters for sunscreen manufacture
03/16/2000DE19841244A1 Verfahren und Vorrichtung zum Herstellen von Tabletten Method and apparatus for the manufacture of tablets
03/16/2000DE19841209A1 Slow-release caffeine tablets produced by direct compression of caffeine-containing plant materials or extracts
03/16/2000DE19837764C1 Verfahren zum Herstellen von klebenden Stanzlingen aus einer endlosen Bahn und nach dem Verfahren hergestellter Stanzling Method for producing adhesive die-cuts from a continuous web and by the method produced diecut
03/16/2000CA2343637A1 Organosilicone compositions for personal care
03/16/2000CA2343234A1 Method and device for producing tablets
03/16/2000CA2342800A1 Nanogel networks and biological agent composition thereof